Navigation Links
Pharmaceutical advances offer new options for health outcomes
Date:5/20/2013

ither treatment-nave or had previously failed standard treatment with peginterferon and ribavirin.

In the phase II study, researchers found that the treatment regimens achieved high sustained virologic response (SVR) rates, an efficacy measure of a hepatitis C treatment, in non-cirrhotic patients with HCV genotype-1 (GT 1). SVR was achieved by 98.7 percent of treatment-nave patients and 93.3 percent of prior nonresponders after 12 weeks of treatment with three direct-acting agents with ribavirin.

"Hepatitis C genotype 1 is the most common type of hepatitis in the U.S., and many of these patients are still quite difficult to treat with current interferon-based therapies," said Frederick Nunes, MD, clinical associate professor of medicine at Penn Medicine. "This includes specific populations such as African Americans and patients with high body mass or pre-diabetes. These results suggest that highly effective regimens like this one may overcome that difficulty, without the need for interferon."


'/>"/>

Contact: Aimee Frank
newsroom@gastro.org
407-685-4030
Digestive Disease Week
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Active Pharmaceutical Ingredients (API) Market in Europe Will Reach $38,255.67 Million By 2017- Pricing and Reimbursement Initiatives Supporting Generic Drug Growth
2. Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data
3. Aeolus Pharmaceuticals To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
4. TraceLink Leads Pharmaceutical Track and Trace, Big Data and Cloud-based Supply Networks Discussion at LogiPharma Europe Conference
5. Corporate Whistle Blower Center Now Urges Pharmaceutical Insiders Or Physicians To Become A Whistleblower If They Can Prove A Drug Maker Was Knowingly Involved In Bribery
6. Pharmaceutical advertising down but not out
7. Pharmaceutical companies: An $84 million marketing effort in the District of Columbia
8. Survey shows medical students have frequent interactions with pharmaceutical companies
9. Radiopharmaceuticals Market - New Industry Research Report Published by Transparency Market Research
10. Sewage lagoons remove most -- but not all -- pharmaceuticals
11. Pharmaceutical Manufacturing in China Industry Research Report – Now Available from IBISWorld
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. Whether ... make things easier for parents, caregivers and children too. Here are three reasons why ... and small become more fluid. When a routine is implemented into a child’s schedule, ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is Baby Safety Month, and ... and stickers to keep little ones' safety top of mind at all times. , ... particular focus. According to the JPMA's Baby Safety Zone website, this year's theme is ...
(Date:9/1/2015)... ... 2015 , ... Curly Hair Solutions™ is thrilled to partner ... partnership between Curly Hair Solutions™ and Trade Secrets allows for nationwide distribution of ... Curly Hair Solutions™ team could not be more delighted to see their line ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... chronic back pain – once required a long, arduous recovery. However, today’s minimally ... less pain, less blood loss and minimal muscle damage. These advantages of minimally ...
(Date:8/31/2015)... ... 31, 2015 , ... Cosmetic Town Journal is an online ... have a successful cosmetic procedure; from publishing encyclopedic medical articles to inform patients ... ready to help. , It is clear that the Cosmetic Town aesthetic surgery ...
Breaking Medicine News(10 mins):Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2
... ... of Africa.,A Virtual Soccer Ball Created by I Imagine Studio To Be Signed by Thousands, ... ... Rotary’s campaign to eradicate the disease, I Imagine Studio has created an interactive, strategic viral ...
... ... premium library of photographs documenting real people and their emotions. Created by assignment photographers ... ) is one of the first stock photo agencies devoted solely to portraiture of ... ...
... ... ... 20, 2010 -- IT-Lifeline, the Northwest’s foremost provider of disaster recovery and business continuity ... that they have entered into a joint marketing agreement to provide a suite of ...
... with erlotinib for people with non-small-cell form of disease ... people with non-small-cell lung cancer, treatment with the drug ... rates, a new study suggests. , Non-small-cell lung ... cases. About half the time, people have advanced disease ...
... THURSDAY, May 20 (HealthDay News) -- Walk a little, and your ... thank you. , That,s the message of a new study that ... of an extremely common condition known as metabolic syndrome, which can ... shows a connection between more walking and better health -- it ...
... ... be presented on June 21 in New York City , ... Provo, Utah (Vocus) May 20, 2010 -- Tahitian Noni ... , , , ,The American Business Awards is the nation’s premier business awards program. All ...
Cached Medicine News:Health News:Rotary International and I Imagine Studio Have Teamed up to Helps Kick Polio out of Africa 2Health News:Rotary International and I Imagine Studio Have Teamed up to Helps Kick Polio out of Africa 3Health News:Citizen Stock Launches Industry's First Rights Managed Database of Images Shot Exclusively Against White 2Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 2Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 3Health News:Post-Chemo Treatment May Boost Lung Cancer Survival 2Health News:More Steps a Day Lead to Better Health 2Health News:More Steps a Day Lead to Better Health 3Health News:Tahitian Noni International Named As Finalist In 2010 American Business Awards 2
(Date:8/31/2015)... 2015  Chiasma, Inc. (NASDAQ: CHMA ), ... for the orphan condition acromegaly, today reported financial ... 2015 and provided a corporate update. ... time for Chiasma, as we successfully completed our ... first New Drug Application (NDA) has been accepted ...
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
(Date:8/31/2015)... Aug. 31, 2015  The departments of Drug and ... at Gaudenzia Concept 90 to raise awareness for International ... in Pennsylvania and help more ... on recovery through the Building Bridges to Recovery ... dying every day to a disease that is fully ...
Breaking Medicine Technology:Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... Identify Unique microRNA Signatures That Will ... Project Will Leverage Rosetta Genomics, Proprietary microRNA Extraction, and Quantification Technologies, ... and Experience ... Patients With High Risk, of Recurrence, who may Benefit From Adjuvant ...
... Accrual and Expansion Plans for SB-509-701 Phase 2 Clinical Trial for ... ... Neuropathy, SAN FRANCISCO, June 6 Sangamo BioSciences,Inc. (Nasdaq: SGMO ... trial (SB-509-701) in subjects with moderate to,severe diabetic neuropathy. Additionally, based upon ...
Cached Medicine Technology:Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 2Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 3Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 4Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 5Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 2Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 3Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 4Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: